Goldman Sachs has coined a distinctive term, 'GRANOLAS,' to spotlight Europe's leading stock market players. This term encompasses a select group of European heavyweights, including GSK, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L'Oréal, LVMH, AstraZeneca, SAP, and Sanofi.